Satoru Kyo

Prof. Dr. Satoru Kyo

Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Japan
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in Nucleic Acids Research
Verified
Journal Article
Open access
SKSatoru Kyo
Satoru Kyo
Telomerase activation is thought to be a critical step in cellular immortalization and carcinogenesis. The human telomerase catalytic subunit (hTERT) is a rate limiting determinant of the enzymatic activity of human telomerase. In the previous study, we identified the proximal 181 bp core promoter responsible for transcriptional activity of the hTERT gene. To identify the regulatory factors of transcription, transient expression assays were performed using hTERT promoter reporter plasmids. Serial deletion assays of the core promoter revealed that the 5'-region containing the E-box, which binds Myc/Max, as well as the 3'-region containing the GC-box, which binds Sp1, are essential for transactivation. The mutations introduced in the E-box or GC-box significantly decreased transcriptional activity of the promoter. Overexpression of Myc/Max or Sp1 led to significant activation of transcription in a cell type-specific manner, while Mad/Max introduction repressed it. However, the effects of Myc/Max on transactivation were marginal when Sp1 sites were mutated. Western blot analysis using various cell lines revealed a positive correlation between c-Myc and Sp1 expression and transcriptional activity of hTERT. Using fibroblast lineages in different stages of transformation, we found that c-Myc and Sp1 were induced to a dramatic extent when cells overcame replicative senescence and obtained immortal characteristics, in association with telomerase activation. These findings suggest that c-Myc and Sp1 cooperatively function as the major determinants of hTERT expression, and that the switching functions of Myc/Max and Mad/Max might also play roles in telomerase regulation.

14 August 2008 in Cancer Science
Verified
Journal Article
Closed access
PDF file
SKSatoru Kyo
Satoru Kyo
MTMasahiro Takakura
Masahiro Takakura
TFToshiyoshi Fujiwara
Toshiyoshi Fujiwara
MIMasaki Inoue
Masaki Inoue

1 December 1999
Verified
Journal Article
Closed access
SKSatoru Kyo
Satoru Kyo
MTM Takakura
M Takakura
TKT Kanaya
T Kanaya
WZW Zhuo
W Zhuo
KFK Fujimoto
K Fujimoto
MIM Inoue
M Inoue


1 April 2006 in Human Pathology
Verified
Journal Article
Closed access
SKSatoru Kyo
Satoru Kyo
JSJ Sakaguchi
J Sakaguchi
SOS Ohno
S Ohno
YMY Mizumoto
Y Mizumoto
YMY Maida
Y Maida
KMK Masutomi
K Masutomi

1 July 2000 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KFKohtaro Fujimoto
Kohtaro Fujimoto
SKSatoru Kyo
Satoru Kyo
MTMasahiro Takakura
Masahiro Takakura
TKTaro Kanaya
Taro Kanaya
YKYasuhide Kitagawa
Yasuhide Kitagawa
MIMasaki Inoue
Masaki Inoue
Human telomerase reverse transcriptase (hTERT) is a catalytic subunit of human telomerase and is a critical determinant of the enzymatic activity of telomerase. Expression of hTERT is known to be regulated mainly at the transcriptional level. In the present study, using transient expression assays, we identified a 400 bp silencer of the hTERT promoter between –776 and –378 upstream of the proximal core promoter. The inhibitory effects of this silencer were enhanced with cellular differentiation. A computer-assisted homology search identified multiple binding motifs for myeloid-specific zinc finger protein 2 (MZF-2) within this region. Mutation introduced in these sites resulted in significant activation of hTERT transcription. Gel shift assays demonstrated that MZF-2 proteins specifically bound to these sites. Overexpression of MZF-2 in cells led to down-regulation of hTERT transcription as well as telomerase activity. These findings suggest that the 400 bp region upstream of the hTERT core promoter that we identified functions as a negative regulatory region and that MZF-2 may be an effector of negative regulation of hTERT.